Full name
"ALERGO-MED" SPECJALISTYCZNA PRZYCHODNIA LEKARSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,7 | 1 | 1,2 | 13,3 |
Gross profit (loss) | 0,9 | 1,1 | 0,9 | -14,7 |
EBITDA | 1 | 2 | 1,1 | -46,5 |
Short time liabilities | 0,1 | 0,3 | 0,1 | -71 |
Other operating costs | 0,1 | 0,1 | 0,3 | 123,7 |
Equity capital | 3,8 | 4,6 | 5,4 | 17,3 |
Operating profit (EBIT) | 0,9 | 1,1 | 1 | -9,7 |
Assets | 3,9 | 4,9 | 5,5 | 11,9 |
Net profit (loss) | 0,9 | 1 | 0,8 | -19,4 |
Cash | 0,5 | 1,6 | 1,5 | -11,4 |
Net income from sale | 1,6 | 4 | 4,9 | 22,4 |
Liabilities and provisions for liabilities | 0,1 | 0,3 | 0,1 | -64,1 |
Working assets | 1,8 | 2,9 | 3,6 | 27,4 |
Other income costs | 0,2 | 0,2 | 0,1 | -34,6 |
Depreciation | 0,1 | 0,9 | 0,1 | -89,8 |
% | % | % | p.p. | |
Profitability of capital | 22,9 | 21,5 | 14,8 | -6,7 |
Equity capital to total assets | 98,1 | 93,3 | 97,8 | 4,5 |
Gross profit margin | 54,1 | 26,9 | 18,8 | -8,1 |
EBITDA Margin | 59,2 | 50 | 21,8 | -28,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 11 | 26 | 6 | -20 |
Current financial liquidity indicator | 35.02302169799805 | 10.13695240020752 | 44.578285217285156 | 34,5 |
Net dept to EBITDA | -0.5142059326171875 | -0.8235986828804016 | -1.3643025159835815 | -0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane